RS64243B1 - Antitumorski agens i sredstvo za poboljšavanje antitumorskog efekta - Google Patents
Antitumorski agens i sredstvo za poboljšavanje antitumorskog efektaInfo
- Publication number
- RS64243B1 RS64243B1 RS20230421A RSP20230421A RS64243B1 RS 64243 B1 RS64243 B1 RS 64243B1 RS 20230421 A RS20230421 A RS 20230421A RS P20230421 A RSP20230421 A RS P20230421A RS 64243 B1 RS64243 B1 RS 64243B1
- Authority
- RS
- Serbia
- Prior art keywords
- antitumor
- effect enhancer
- agent
- antitumor agent
- antitumor effect
- Prior art date
Links
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 239000003623 enhancer Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013184684 | 2013-09-06 | ||
| PCT/JP2014/073436 WO2015034032A1 (ja) | 2013-09-06 | 2014-09-05 | 抗腫瘍剤及び抗腫瘍効果増強剤 |
| EP14842538.2A EP3042669B1 (en) | 2013-09-06 | 2014-09-05 | Antitumor agent and antitumor effect enhancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS64243B1 true RS64243B1 (sr) | 2023-06-30 |
Family
ID=52628493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20230421A RS64243B1 (sr) | 2013-09-06 | 2014-09-05 | Antitumorski agens i sredstvo za poboljšavanje antitumorskog efekta |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US9943537B2 (sr) |
| EP (2) | EP4201424A1 (sr) |
| JP (2) | JP6425653B2 (sr) |
| KR (1) | KR101993963B1 (sr) |
| AU (1) | AU2014316030C1 (sr) |
| CY (1) | CY1126037T1 (sr) |
| DK (1) | DK3042669T3 (sr) |
| ES (1) | ES2946472T3 (sr) |
| FI (2) | FI3042669T3 (sr) |
| FR (1) | FR24C1005I1 (sr) |
| HR (1) | HRP20230523T1 (sr) |
| HU (2) | HUE062034T2 (sr) |
| LT (1) | LT3042669T (sr) |
| NO (1) | NO2024005I1 (sr) |
| PL (1) | PL3042669T3 (sr) |
| PT (1) | PT3042669T (sr) |
| RS (1) | RS64243B1 (sr) |
| RU (1) | RU2682161C2 (sr) |
| SI (1) | SI3042669T1 (sr) |
| TW (1) | TWI641385B (sr) |
| UA (1) | UA121538C2 (sr) |
| WO (1) | WO2015034032A1 (sr) |
| ZA (1) | ZA201602258B (sr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3042669T3 (pl) | 2013-09-06 | 2023-06-26 | Taiho Pharmaceutical Co., Ltd. | Środek przeciwnowotworowy i środek wzmacniający efekt przeciwnowotworowy |
| WO2017119484A1 (ja) | 2016-01-08 | 2017-07-13 | 大鵬薬品工業株式会社 | 免疫調節剤を含有する抗腫瘍剤及び抗腫瘍効果増強剤 |
| JP2019511547A (ja) * | 2016-04-13 | 2019-04-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 結腸直腸癌を治療するためのニンテダニブ、トリフルリジンおよびチピラシルの医薬組合せ |
| EP3646887A4 (en) * | 2017-06-30 | 2021-03-24 | Korea Advanced Institute of Science and Technology | CONJUGATE OF VEGF GRAB PROTEIN AND MEDICINAL PRODUCTS AND USES THEREOF |
| KR20220154986A (ko) | 2021-05-14 | 2022-11-22 | 윤상은 | 휴대용 마스크끈 절단기 |
| AR127893A1 (es) * | 2021-12-10 | 2024-03-06 | Servier Lab | Terapia del cáncer dirigida a egfr |
| AU2023208566A1 (en) | 2022-01-21 | 2024-07-11 | Chugai Seiyaku Kabushiki Kaisha | Medicine for treating or preventing cancer |
| WO2024177036A1 (ja) * | 2023-02-20 | 2024-08-29 | 大鵬薬品工業株式会社 | Ｆｔｄ・ｔｐｉ配合剤、ｐｄ－１経路アンタゴニスト、及びｖｅｇｆ経路アンタゴニストの併用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69629156T2 (de) | 1995-03-29 | 2004-05-06 | Taiho Pharmaceutical Co. Ltd. | Uracilderivate und diese enthaltende antitumoreffekt-verstärker sowie antitumormittel |
| US7312243B1 (en) * | 2003-08-29 | 2007-12-25 | Jay Pravda | Materials and methods for treatment of gastrointestinal disorders |
| SI1849470T2 (sl) | 2005-01-26 | 2024-05-31 | Taiho Pharmaceutical Co., Ltd. | Zdravilo proti raku, ki vsebuje alfa,alfa,alfa-trifluorotimidin in zaviralec timidin-fosforilaze |
| US7799783B2 (en) * | 2005-01-26 | 2010-09-21 | Taiho Pharmaceutical Co., Ltd. | Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor |
| PT2979701T (pt) | 2013-03-27 | 2020-10-20 | Taiho Pharmaceutical Co Ltd | Agente antitumoral que inclui cloridrato de irinotecano hidratado em dose baixa |
| JP6002835B2 (ja) * | 2013-03-27 | 2016-10-05 | 大鵬薬品工業株式会社 | 低用量イリノテカン塩酸塩水和物を含有する抗腫瘍剤 |
| PL3042669T3 (pl) | 2013-09-06 | 2023-06-26 | Taiho Pharmaceutical Co., Ltd. | Środek przeciwnowotworowy i środek wzmacniający efekt przeciwnowotworowy |
-
2014
- 2014-09-05 PL PL14842538.2T patent/PL3042669T3/pl unknown
- 2014-09-05 US US14/916,878 patent/US9943537B2/en active Active
- 2014-09-05 UA UAA201603578A patent/UA121538C2/uk unknown
- 2014-09-05 EP EP23154967.6A patent/EP4201424A1/en active Pending
- 2014-09-05 SI SI201432026T patent/SI3042669T1/sl unknown
- 2014-09-05 RS RS20230421A patent/RS64243B1/sr unknown
- 2014-09-05 HR HRP20230523TT patent/HRP20230523T1/hr unknown
- 2014-09-05 JP JP2015535524A patent/JP6425653B2/ja active Active
- 2014-09-05 AU AU2014316030A patent/AU2014316030C1/en active Active
- 2014-09-05 WO PCT/JP2014/073436 patent/WO2015034032A1/ja active Application Filing
- 2014-09-05 FI FIEP14842538.2T patent/FI3042669T3/fi active
- 2014-09-05 LT LTEPPCT/JP2014/073436T patent/LT3042669T/lt unknown
- 2014-09-05 ES ES14842538T patent/ES2946472T3/es active Active
- 2014-09-05 EP EP14842538.2A patent/EP3042669B1/en active Active
- 2014-09-05 RU RU2016112421A patent/RU2682161C2/ru active
- 2014-09-05 DK DK14842538.2T patent/DK3042669T3/da active
- 2014-09-05 KR KR1020167005952A patent/KR101993963B1/ko active IP Right Grant
- 2014-09-05 HU HUE14842538A patent/HUE062034T2/hu unknown
- 2014-09-05 PT PT148425382T patent/PT3042669T/pt unknown
- 2014-09-05 TW TW103130882A patent/TWI641385B/zh active
-
2016
- 2016-04-05 ZA ZA2016/02258A patent/ZA201602258B/en unknown
-
2018
- 2018-01-15 JP JP2018004516A patent/JP6557744B2/ja active Active
-
2023
- 2023-06-07 CY CY20231100271T patent/CY1126037T1/el unknown
-
2024
- 2024-01-24 FR FR24C1005C patent/FR24C1005I1/fr active Active
- 2024-01-24 HU HUS2400001C patent/HUS2400001I1/hu unknown
- 2024-01-25 FI FIC20240002C patent/FIC20240002I1/fi unknown
- 2024-01-25 NO NO2024005C patent/NO2024005I1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274355B (en) | Aza-pyridone compounds and their uses | |
| HUS2400001I1 (hu) | Tumorellenes szer és tumorellenes hatás erõsítõ | |
| ZA201505735B (en) | Cancer drug and uses | |
| LT2958944T (lt) | Antikūno prieš dll3 ir pbd konjugatai bei jų panaudojimas | |
| IL240527B (en) | Composition of dentures and denture system | |
| GB201323008D0 (en) | Compounds and uses thereof | |
| HK1214333A1 (zh) | 托架以及使用 | |
| IL240248A0 (en) | Met-binding substances and their uses | |
| GB201300707D0 (en) | Compounds and processes | |
| GB201307233D0 (en) | Compounds and uses thereof | |
| IL245157A0 (en) | Antitumor factor | |
| HK1219233A1 (zh) | 美羅培南衍生物及其用途 | |
| GB201320992D0 (en) | Complex and uses thereof | |
| GB201309180D0 (en) | Compounds and Their Uses | |
| GB201314610D0 (en) | Compounds and their uses | |
| GB201306248D0 (en) | Compounds and their uses | |
| HK1222560A1 (zh) | 抗流感組合物和方法 | |
| ZA201601880B (en) | Hetero-transglycosylase and uses thereof | |
| HK1217965A1 (zh) | 降低了雜味的清涼感持續劑 | |
| EP3037100A4 (en) | MEANS TO PREVENT MUSCLE ATROPHY | |
| GB201321706D0 (en) | Complexes and cataytic processes | |
| GB201321027D0 (en) | Prescribe and treat | |
| GB201301393D0 (en) | Kiddibidet and pottibidet | |
| GB201320161D0 (en) | Compounds and their uses | |
| GB201304166D0 (en) | CelebQuiff and Instant Quiff |